- Home
- NVRO vs RZLT Comparison
NVRO vs RZLT Comparison
Compare NVRO & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVRO
- RZLT
- Stock Information
- Founded
- NVRO 2006
- RZLT 2010
- Country
- NVRO United States
- RZLT United States
- Employees
- NVRO N/A
- RZLT N/A
- Industry
- NVRO Medical/Dental Instruments
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- NVRO Health Care
- RZLT Health Care
- Exchange
- NVRO Nasdaq
- RZLT Nasdaq
- Market Cap
- NVRO 134.5M
- RZLT 292.0M
- IPO Year
- NVRO 2014
- RZLT N/A
- Fundamental
- Price
- NVRO $3.69
- RZLT $5.17
- Analyst Decision
- NVRO Hold
- RZLT Strong Buy
- Analyst Count
- NVRO 14
- RZLT 8
- Target Price
- NVRO $7.97
- RZLT $11.63
- AVG Volume (30 Days)
- NVRO 416.5K
- RZLT 377.7K
- Earning Date
- NVRO 02-19-2025
- RZLT 02-11-2025
- Dividend Yield
- NVRO N/A
- RZLT N/A
- EPS Growth
- NVRO N/A
- RZLT N/A
- EPS
- NVRO N/A
- RZLT N/A
- Revenue
- NVRO $419,146,000.00
- RZLT N/A
- Revenue This Year
- NVRO N/A
- RZLT N/A
- Revenue Next Year
- NVRO $0.65
- RZLT N/A
- P/E Ratio
- NVRO N/A
- RZLT N/A
- Revenue Growth
- NVRO N/A
- RZLT N/A
- 52 Week Low
- NVRO $3.52
- RZLT $0.90
- 52 Week High
- NVRO $21.74
- RZLT $6.19
- Technical
- Relative Strength Index (RSI)
- NVRO 43.89
- RZLT 55.42
- Support Level
- NVRO $3.60
- RZLT $4.70
- Resistance Level
- NVRO $3.90
- RZLT $5.09
- Average True Range (ATR)
- NVRO 0.28
- RZLT 0.33
- MACD
- NVRO 0.01
- RZLT 0.07
- Stochastic Oscillator
- NVRO 39.56
- RZLT 93.63
About NVRO Nevro Corp.
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.